Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
INTERPARFUMS INC
Report date December 30, 2016 · Filed January 04, 2017
Section 16 reporting ended · disclosed 2017-01-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,625 |
Ending reported balance
After 2016-12-30 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2016-12-30 · Exercise / conversion · Acquired 1,500 · Balance 3,125 Row 2 · 2016-12-30 · Sale · Disposed 1,500 · Balance 1,625 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $27.80 · Expires 2020-12-30 | Direct | 0 |
Reported balance
After 2016-12-30 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2016-12-30 · Exercise / conversion · Disposed 1,500 · Balance 0 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $23.61 · Expires 2021-12-30 | Direct | 1,500 |
Reported balance
Holding disclosure · report date 2016-12-30 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 1,500 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $23.61 · Expires 2021-12-30 | Direct | 1,500 |
Reported balance
Holding disclosure · report date 2016-12-30 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 1,500 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $23.61 · Expires 2021-12-30 | Direct | 1,500 |
Reported balance
Holding disclosure · report date 2016-12-30 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 1,500 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $23.61 · Expires 2021-12-30 | Direct | 1,500 |
Reported balance
Holding disclosure · report date 2016-12-30 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 1,500 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $23.61 · Expires 2021-12-30 | Direct | 1,500 |
Reported balance
Holding disclosure · report date 2016-12-30 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 1,500 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $15.59 · Expires 2017-12-29 | Direct | 1,500 |
Reported balance
Holding disclosure · report date 2016-12-30 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 1,500 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $19.33 · Expires 2018-12-30 | Direct | 1,500 |
Reported balance
Holding disclosure · report date 2016-12-30 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 1,500 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $19.33 · Expires 2018-12-30 | Direct | 1,500 |
Reported balance
Holding disclosure · report date 2016-12-30 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 1,500 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $35.75 · Expires 2019-12-30 | Direct | 1,500 |
Reported balance
Holding disclosure · report date 2016-12-30 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 1,500 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $35.75 · Expires 2019-12-30 | Direct | 1,500 |
Reported balance
Holding disclosure · report date 2016-12-30 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 1,500 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $35.75 · Expires 2019-12-30 | Direct | 1,500 |
Reported balance
Holding disclosure · report date 2016-12-30 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 1,500 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $35.75 · Expires 2019-12-30 | Direct | 1,500 |
Reported balance
Holding disclosure · report date 2016-12-30 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 1,500 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $35.75 · Expires 2019-12-30 | Direct | 1,500 |
Reported balance
Holding disclosure · report date 2016-12-30 · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · Balance 1,500 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $27.80 · Expires 2020-12-30 | Direct | 1,500 |
Reported balance
Holding disclosure · report date 2016-12-30 · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · Balance 1,500 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $27.80 · Expires 2020-12-30 | Direct | 1,500 |
Reported balance
Holding disclosure · report date 2016-12-30 · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · Balance 1,500 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $27.80 · Expires 2020-12-30 | Direct | 1,500 |
Reported balance
Holding disclosure · report date 2016-12-30 · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · Balance 1,500 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $27.80 · Expires 2020-12-30 | Direct | 1,500 |
Reported balance
Holding disclosure · report date 2016-12-30 · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · Balance 1,500 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 30, 2016 Filed Jan 4, 2017 22:29 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 1,500 | $0.00 Strike: $27.80 | $0.00 |
DisclosureSEC source: 0001638599-17-000019 · doc4_4443.xml · derivative · entry 16 Clarke Henry B. · CIK 0001424398 · President Inter Parfums USA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2020-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 22:29 UTC | INTERPARFUMS INC IPAR · Entity 4092 | SaleCommon Stock | 1,500 | $32.75 | $49,126.50 |
DisclosureSEC source: 0001638599-17-000019 · doc4_4443.xml · nonDerivative · entry 2 Clarke Henry B. · CIK 0001424398 · President Inter Parfums USA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,625 Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 22:29 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionCommon Stock | 1,500 | $27.80 | $41,692.50 |
DisclosureSEC source: 0001638599-17-000019 · doc4_4443.xml · nonDerivative · entry 1 Clarke Henry B. · CIK 0001424398 · President Inter Parfums USA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.